OA06.06 Clinical/Biomarker Data for Neoadjuvant Atezolizumab in Resectable Stage IB-IIIB NSCLC: Primary Analysis in the LCMC3 Study

David P. Carbone, J. Lee, Mark G. Kris, Ignacio I. Wistuba, David J. Kwiatkowski, Dwight H. Owen, Paul A. Bunn, Bruce E. Johnson, Filiz Öezkan, Yuan Tang, Edwin R. Parra, Gerard Lozanski, Chris Rivard, Katja Schulze, A. Nicholas, Ann Johnson, Jessica M. Grindheim, D. Shames, S. Phan, Eric M. Toloza, Eric B. Haura, Ciaran McNamee, Justin F. Gainor, Alexander Patterson, S. Waqar, Dan J. Raz, Karen L. Reckamp, David J. Finley, Valerie W. Rusch, Jamie E. Chaft, John H. Abel